HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?

Abstract
Recombinant activated factor VII (rFVIIa, 'NovoSeven') is indicated for the treatment of bleeding in patients with haemophilia and inhibitors to factors VIII or IX. However, by virtue of its ability to promote thrombin generation on the platelet surface rFVIIa may also be effective in non-haemophilic bleeding, for example, in patients with thrombocytopenic or oral anticoagulant-induced haemorrhage. Studies in thrombocytopenia indicate that rFVIIa increases the generation of thrombin at the site of injury, leading to the control of bleeding episodes in these conditions. Additionally, preclinical and early clinical evidence has demonstrated the ability of rFVIIa to normalise prothrombin times and international normalised ratios in situations of over-anticoagulation. Although initial observations indicate that rFVIIa may be fast, efficacious, and safe in reversing oral anticoagulant-induced bleeds and those associated with thrombocytopenia, randomised, double-blind, placebo-controlled trials must be conducted to confirm its utility in these and other investigational uses.
AuthorsCraig Kessler
JournalIntensive care medicine (Intensive Care Med) Vol. 28 Suppl 2 Pg. S228-34 (Oct 2002) ISSN: 0342-4642 [Print] United States
PMID12404091 (Publication Type: Journal Article, Review)
Chemical References
  • Anticoagulants
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa
Topics
  • Anticoagulants (adverse effects)
  • Factor VII (therapeutic use)
  • Factor VIIa
  • Hemorrhage (etiology, prevention & control)
  • Humans
  • Recombinant Proteins (therapeutic use)
  • Thrombocytopenia (complications, diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: